Inova acquires IN-PART, a meeting platform for collaboration between academia and industry.
Lyon, France, February 8, 2022 – After recent acquisition of the European media on biotechnologies Labiotech, Inova acquires now IN-PART, a digital networking platform dedicated to collaboration between academia and industry. These strategic moves consolidate Inova's position as a leader and pioneer in the digitalization of the world of partnership biopharmaceutical, made possible by the investment of 60 million euros from the international private equity firm Carlyle (NASDAQ: CG) and the reaffirmation of NextStage AM's support in 2021.
Inova supports through its solutions more than 160 customers worldwide, including many of the largest pharmaceutical companies, and is at the forefront of the digital transformation of the business of partnership biopharmaceutical. Inova's flagship product, "Inova Partnering Platform", is a collaborative tool that manages all potential partnerships related to innovations outsourced to laboratories and biotechs, allowing its customers to generate, prospect, execute transactions, to establish alliances and to organize virtual events.
IN-PART develops adapted digital solutions that stimulate the impact of research by simplifying the first connection between teams from academia and industries from all sectors. IN-PART's matchmaking platform, "Connect", is used by more than 250 universities and research institutes to find new partners for commercialization in more than 6 companies. Additionally, their bespoke discovery platform, "Discover", is used by industry leaders to engage academics, technology transfer offices, and research service departments at over 000 institutes with specific R&D challenges or requirements.
This acquisition is a major milestone for academia-industry partnerships. While IN-PART will continue to maintain and develop its platforms for all research sectors, this combination will give it access to Inova's software infrastructure, as well as its market-leading teams in of products and marketing. In return, Inova customers will benefit from access to IN-PART's search and discovery platforms, as well as leveraging best practices in matchmaking technology. By creating a stronger and more connected research ecosystem, this acquisition will ensure that academic breakthroughs will have an even greater impact on society.
“The Inova team is growing with talents and resources that take life science partnerships to the next level. There is a growing consensus in the world of biopharmaceutical partnerships that academia is the game changer. However, our customers often report how difficult it is to navigate through all the science produced by academics. IN-PART has built an impressive digital solution to address precisely this challenge, and this acquisition allows us to now come full circle on our mission and include academia in the world of next-generation partnerships. Together, we're helping untapped science reach market through smart partnerships” Gilles Toulemonde, founder and CEO of Inova.
“With Inova, we have found great strategic alignment with our entire technology base in terms of company values and culture. This will give us access to many more resources and expertise for IN-PART to accelerate its growth and realize its vision of connecting the academic-industry ecosystem, in all areas of research and sectors with which we work. are working. This is a great moment for us and we look forward to the next part of our adventure with the amazing team at Inova. » Patrick Speedie, co-founder and director of IN-PART.
“It was clear from the start that with Inova there was a strategic synergy across our technology bases but also an alignment in terms of value and corporate culture. Inova provides its clients with industry lead partnering software that seamlessly integrates with our matchmaking platform and research solution, Discover. The union of our companies, as well as the exchange of expertise and technology within our teams, will allow us to accelerate the pace at which we contribute to the emergence of the next generation of treatments and technologies. » Robin Knight, co-founder and director of IN-PART.
About Inova
Inova is a cloud-based solution designed to help science-based companies more effectively identify and manage their biopharmaceutical opportunities. It offers a platform for organizing events, obtaining licenses, partnering opportunities, concluding agreements and alliances. Inova has more than 125 employees distributed between its headquarters in Lyon, France, and its offices in New York, Denver and Tokyo. More information is available on Inova.io.
Follow Inova on LinkedIn et Twitter.
About IN PART
IN-PART provides digital meeting platforms for teams in academia and industry who strive to have greater positive impact through collaboration. Launched in 2014, IN-PART has offices in Sheffield and London, with a team of 50 staff, mostly from STEM backgrounds, managing and overseeing their platforms. Further information is available at in-part.com.
Follow IN-PART on LinkedIn et Twitter.
Media contact:
Innovates
Sarah Issa
+33 6 24 86 81 69
sarah.issa@inova.io
In Part
Alex Stockham
+44 (0) 7474 887 855
alex@in-part.co.uk